Global schizophrenia drugs market is expected to register a CAGR of around 4% over the period of 2021-2027. The schizophrenia drugs market is anticipated to grow on account of the increase in the prevalence of schizophrenia, and the rising demand for improved medication and treatment is expected to drive the market. For instance, In the U.S. alone, the disorder affects approximately 3.5 million...

Global schizophrenia drugs market is expected to register a CAGR of around 4% over the period of 2021-2027. The schizophrenia drugs market is anticipated to grow on account of the increase in the prevalence of schizophrenia, and the rising demand for improved medication and treatment is expected to drive the market. For instance, In the U.S. alone, the disorder affects approximately 3.5 million...

Global schizophrenia drugs market is expected to register a CAGR of around 4% over the period of 2021-2027. The schizophrenia drugs market is anticipated to grow on account of the increase in the prevalence of schizophrenia, and the rising demand for improved medication and treatment is expected to drive the market. For instance, In the U.S. alone, the disorder affects approximately 3.5 million...

The global schizophrenia drugs market is projected to exhibit a modest growth, at a CAGR of around 2.7%,during the forecast period. There has been a rise in stress management and mental health awareness initiatives across the globe. The need for these awareness programs is necessary as well due to the increasing level of mental disorders due to high stress in individuals. There are various...

Schizophrenia is a disorder which was an unknown field until the past few decades, let alone its treatment. However, the schizophrenia market has been rising over recent years, with the availability of plenty of treatment options. The emergence of antipsychotic medicines and biosimilars that has introduced the world with the new age schizophrenia treatments are propelling the market...